187 related articles for article (PubMed ID: 27071511)
1. Associations of serum n-3 and n-6 polyunsaturated fatty acids with plasma natriuretic peptides.
Daneshmand R; Kurl S; Tuomainen TP; Virtanen JK
Eur J Clin Nutr; 2016 Aug; 70(8):963-9. PubMed ID: 27071511
[TBL] [Abstract][Full Text] [Related]
2. Fatty acids as determinants of in-vivo lipid peroxidation: the EFFGE study in Eastern Finnish hypertensive and non-hypertensive subjects.
Kaikkonen JE; Vilppo T; Asikainen J; Voutilainen S; Kurl S; Salonen JT
Ann Med; 2013 Sep; 45(5-6):455-64. PubMed ID: 23952918
[TBL] [Abstract][Full Text] [Related]
3. The association of serum long-chain n-3 PUFA and hair mercury with exercise cardiac power in men.
Tajik B; Kurl S; Tuomainen TP; Virtanen JK
Br J Nutr; 2016 Aug; 116(3):487-95. PubMed ID: 27255152
[TBL] [Abstract][Full Text] [Related]
4. Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men.
Reinders I; Virtanen JK; Brouwer IA; Tuomainen TP
Eur J Clin Nutr; 2012 Jun; 66(6):736-41. PubMed ID: 22113248
[TBL] [Abstract][Full Text] [Related]
5. Association between serum long-chain omega-3 polyunsaturated fatty acids and cognitive performance in elderly men and women: The Kuopio Ischaemic Heart Disease Risk Factor Study.
D'Ascoli TA; Mursu J; Voutilainen S; Kauhanen J; Tuomainen TP; Virtanen JK
Eur J Clin Nutr; 2016 Aug; 70(8):970-5. PubMed ID: 27071510
[TBL] [Abstract][Full Text] [Related]
6. Serum long-chain omega-3 polyunsaturated fatty acids and risk of orthostatic hypotension.
Nyantika AN; Tuomainen TP; Kauhanen J; Voutilainen S; Virtanen JK
Hypertens Res; 2016 Jul; 39(7):543-7. PubMed ID: 26911234
[TBL] [Abstract][Full Text] [Related]
7. Associations of the serum long-chain omega-3 polyunsaturated fatty acids and hair mercury with heart rate-corrected QT and JT intervals in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Tajik B; Kurl S; Tuomainen TP; Virtanen JK
Eur J Nutr; 2017 Oct; 56(7):2319-2327. PubMed ID: 27431893
[TBL] [Abstract][Full Text] [Related]
8. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
9. The associations of serum n-6 polyunsaturated fatty acids with serum C-reactive protein in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Virtanen JK; Mursu J; Voutilainen S; Tuomainen TP
Eur J Clin Nutr; 2018 Mar; 72(3):342-348. PubMed ID: 29515239
[TBL] [Abstract][Full Text] [Related]
10. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
11. Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.
Forouhi NG; Imamura F; Sharp SJ; Koulman A; Schulze MB; Zheng J; Ye Z; Sluijs I; Guevara M; Huerta JM; Kröger J; Wang LY; Summerhill K; Griffin JL; Feskens EJ; Affret A; Amiano P; Boeing H; Dow C; Fagherazzi G; Franks PW; Gonzalez C; Kaaks R; Key TJ; Khaw KT; Kühn T; Mortensen LM; Nilsson PM; Overvad K; Pala V; Palli D; Panico S; Quirós JR; Rodriguez-Barranco M; Rolandsson O; Sacerdote C; Scalbert A; Slimani N; Spijkerman AM; Tjonneland A; Tormo MJ; Tumino R; van der A DL; van der Schouw YT; Langenberg C; Riboli E; Wareham NJ
PLoS Med; 2016 Jul; 13(7):e1002094. PubMed ID: 27434045
[TBL] [Abstract][Full Text] [Related]
12. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
Rubattu S; Barbato A; Marchitti S; Iacone R; Di Castro S; Evangelista A; Stanzione R; Ippolito R; Sciarretta S; Palmieri L; Volpe M; Strazzullo P;
J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
[TBL] [Abstract][Full Text] [Related]
13. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
Hypertension; 2005 Oct; 46(4):660-6. PubMed ID: 16129819
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
17. Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study.
Vanhala M; Saltevo J; Soininen P; Kautiainen H; Kangas AJ; Ala-Korpela M; Mäntyselkä P
Am J Epidemiol; 2012 Aug; 176(3):253-60. PubMed ID: 22791741
[TBL] [Abstract][Full Text] [Related]
18. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
[TBL] [Abstract][Full Text] [Related]
19. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
Kouloubinis A; Kaklamanis L; Ziras N; Sofroniadou S; Makaritsis K; Adamopoulos S; Revela I; Athanasiou A; Mavroudis D; Georgoulias V
Int J Cardiol; 2007 Nov; 122(3):195-201. PubMed ID: 17289172
[TBL] [Abstract][Full Text] [Related]
20. Association between the ratio of serum n-3 to n-6 polyunsaturated fatty acids and acute coronary syndrome in non-obese patients with coronary risk factor: a multicenter cross-sectional study.
Nishizaki Y; Shimada K; Tani S; Ogawa T; Ando J; Takahashi M; Yamamoto M; Shinozaki T; Miyazaki T; Miyauchi K; Nagao K; Hirayama A; Yoshimura M; Komuro I; Nagai R; Daida H
BMC Cardiovasc Disord; 2020 Apr; 20(1):160. PubMed ID: 32252654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
